GRP
OKUR

Global Retirement Partners’s OnKure Therapeutics OKUR Stock Holding History

Global Retirement Partners’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10
Closed -$735 – 3487
2023
Q3 		$735 Hold
10
– – ﹤0.01% 2851
2023
Q2 		$656 Hold
10
– – ﹤0.01% 2887
2023
Q1 		$987 Buy
+10
New +$362 ﹤0.01% 2738

Other funds holding OKUR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Global Retirement Partners's OKUR Position: Q4 2023 in Review

Global Retirement Partners sold out of OnKure Therapeutics (OKUR) in Q4 2023, closing a stake of 10 shares — an estimated $735 sold.

Global Retirement Partners first reported a position in OKUR in Q1 2023 and held it in 3 quarters. The position peaked at $987 in Q1 2023. 68 funds tracked by Wall St. Rank hold OKUR as of Q4 2023.

  • Global Retirement Partners reported no remaining OnKure Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Global Retirement Partners sold 10 OnKure Therapeutics shares in Q4 2023, an estimated $735.
  • Global Retirement Partners first reported a position in OnKure Therapeutics in Q1 2023 and held it in 3 quarters.
  • Global Retirement Partners's OnKure Therapeutics position peaked at $987 in Q1 2023.
  • 68 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q4 2023.

Based on Global Retirement Partners's 13F filing for Q4 2023, filed 18 Jan 2024.